Biomerica, Inc. (BMRA)
USD 0.54
(-5.4%)
USD 0.54
(-5.4%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 6.97 Million USD | -9.01% |
| 2023 | 7.66 Million USD | 2.1% |
| 2022 | 7.51 Million USD | 7.01% |
| 2021 | 7.01 Million USD | 67.74% |
| 2020 | 4.18 Million USD | 12.95% |
| 2019 | 3.7 Million USD | 14.48% |
| 2018 | 3.23 Million USD | 8.73% |
| 2017 | 2.97 Million USD | 26.6% |
| 2016 | 2.35 Million USD | 6.26% |
| 2015 | 2.21 Million USD | 4.57% |
| 2014 | 2.11 Million USD | 10.55% |
| 2013 | 1.91 Million USD | 6.79% |
| 2012 | 1.79 Million USD | 8.1% |
| 2011 | 1.65 Million USD | -13.89% |
| 2010 | 1.92 Million USD | 11.79% |
| 2009 | 1.72 Million USD | 5.91% |
| 2008 | 1.62 Million USD | -5.73% |
| 2007 | 1.72 Million USD | -31.07% |
| 2006 | 2.5 Million USD | -24.62% |
| 2005 | 3.31 Million USD | 2.7% |
| 2004 | 3.23 Million USD | 4.0% |
| 2003 | 3.1 Million USD | 3.58% |
| 2002 | 3 Million USD | -14.09% |
| 2001 | 3.49 Million USD | -48.79% |
| 2000 | 6.82 Million USD | 74.91% |
| 1999 | 3.9 Million USD | 0.0% |
| 1998 | 3.9 Million USD | 14.71% |
| 1997 | 3.4 Million USD | -8.11% |
| 1996 | 3.7 Million USD | -7.5% |
| 1995 | 4 Million USD | 5.26% |
| 1994 | 3.8 Million USD | 8.57% |
| 1993 | 3.5 Million USD | -20.45% |
| 1992 | 4.4 Million USD | -21.43% |
| 1991 | 5.6 Million USD | 33.33% |
| 1990 | 4.2 Million USD | 223.08% |
| 1989 | 1.3 Million USD | -35.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.93 Million USD | 17.58% |
| 2024 Q1 | 1.64 Million USD | -11.83% |
| 2024 Q4 | 1.54 Million USD | -16.37% |
| 2024 Q3 | 1.85 Million USD | -4.24% |
| 2024 FY | 6.97 Million USD | -9.01% |
| 2023 FY | 7.66 Million USD | 2.1% |
| 2023 Q3 | 1.77 Million USD | -12.22% |
| 2023 Q1 | 2.01 Million USD | -15.26% |
| 2023 Q2 | 2.01 Million USD | 0.15% |
| 2023 Q4 | 1.86 Million USD | 5.26% |
| 2022 Q4 | 2.37 Million USD | 33.53% |
| 2022 Q1 | 1.45 Million USD | -3.07% |
| 2022 Q2 | 1.9 Million USD | 31.01% |
| 2022 Q3 | 1.78 Million USD | -6.35% |
| 2022 FY | 7.51 Million USD | 7.01% |
| 2021 FY | 7.01 Million USD | 67.74% |
| 2021 Q1 | 1.83 Million USD | 50.58% |
| 2021 Q3 | 1.84 Million USD | 0.02% |
| 2021 Q2 | 1.84 Million USD | 0.11% |
| 2021 Q4 | 1.49 Million USD | -18.69% |
| 2020 Q1 | 876.86 Thousand USD | -7.27% |
| 2020 Q3 | 1.12 Million USD | 17.55% |
| 2020 Q2 | 958.61 Thousand USD | 9.32% |
| 2020 FY | 4.18 Million USD | 12.95% |
| 2020 Q4 | 1.22 Million USD | 8.4% |
| 2019 Q1 | 792 Thousand USD | -13.2% |
| 2019 Q2 | 893.99 Thousand USD | 12.88% |
| 2019 Q3 | 1.07 Million USD | 20.04% |
| 2019 Q4 | 945.62 Thousand USD | -11.88% |
| 2019 FY | 3.7 Million USD | 14.48% |
| 2018 Q2 | 794.92 Thousand USD | 7.34% |
| 2018 Q1 | 740.59 Thousand USD | -6.27% |
| 2018 Q3 | 788.21 Thousand USD | -0.84% |
| 2018 FY | 3.23 Million USD | 8.73% |
| 2018 Q4 | 912.41 Thousand USD | 15.76% |
| 2017 Q4 | 790.16 Thousand USD | 3.0% |
| 2017 Q1 | 642.59 Thousand USD | 4.0% |
| 2017 FY | 2.97 Million USD | 26.6% |
| 2017 Q2 | 776.22 Thousand USD | 20.79% |
| 2017 Q3 | 767.14 Thousand USD | -1.17% |
| 2016 Q2 | 621.81 Thousand USD | 24.95% |
| 2016 Q4 | 617.89 Thousand USD | 0.7% |
| 2016 Q1 | 497.65 Thousand USD | -5.55% |
| 2016 FY | 2.35 Million USD | 6.26% |
| 2016 Q3 | 613.62 Thousand USD | -1.32% |
| 2015 FY | 2.21 Million USD | 4.57% |
| 2015 Q3 | 594.36 Thousand USD | 6.69% |
| 2015 Q4 | 526.9 Thousand USD | -11.35% |
| 2015 Q1 | 534.02 Thousand USD | -15.6% |
| 2015 Q2 | 557.1 Thousand USD | 4.32% |
| 2014 Q1 | 434.05 Thousand USD | -6.32% |
| 2014 FY | 2.11 Million USD | 10.55% |
| 2014 Q3 | 545.94 Thousand USD | 8.51% |
| 2014 Q2 | 503.14 Thousand USD | 15.92% |
| 2014 Q4 | 632.7 Thousand USD | 15.89% |
| 2013 FY | 1.91 Million USD | 6.79% |
| 2013 Q4 | 463.32 Thousand USD | -8.92% |
| 2013 Q3 | 508.71 Thousand USD | -2.49% |
| 2013 Q2 | 521.7 Thousand USD | 24.18% |
| 2013 Q1 | 420.11 Thousand USD | -13.73% |
| 2012 Q2 | 473.31 Thousand USD | 18.47% |
| 2012 Q3 | 432.35 Thousand USD | -8.66% |
| 2012 Q4 | 486.98 Thousand USD | 12.64% |
| 2012 Q1 | 399.52 Thousand USD | 13.43% |
| 2012 FY | 1.79 Million USD | 8.1% |
| 2011 FY | 1.65 Million USD | -13.89% |
| 2011 Q3 | 426.46 Thousand USD | -10.81% |
| 2011 Q1 | 401.01 Thousand USD | -36.38% |
| 2011 Q2 | 478.16 Thousand USD | 19.24% |
| 2011 Q4 | 352.21 Thousand USD | -17.41% |
| 2010 Q4 | 630.3 Thousand USD | 57.36% |
| 2010 Q2 | 522.71 Thousand USD | 40.62% |
| 2010 FY | 1.92 Million USD | 11.79% |
| 2010 Q1 | 371.71 Thousand USD | -14.77% |
| 2010 Q3 | 400.55 Thousand USD | -23.37% |
| 2009 Q3 | 460.11 Thousand USD | 4.55% |
| 2009 Q4 | 436.13 Thousand USD | -5.21% |
| 2009 Q1 | 385.87 Thousand USD | 1.3% |
| 2009 Q2 | 440.08 Thousand USD | 14.05% |
| 2009 FY | 1.72 Million USD | 5.91% |
| 2008 Q4 | 380.91 Thousand USD | 1.55% |
| 2008 FY | 1.62 Million USD | -5.73% |
| 2008 Q2 | 480.08 Thousand USD | 23.09% |
| 2008 Q1 | 390.02 Thousand USD | -36.12% |
| 2008 Q3 | 375.11 Thousand USD | -21.87% |
| 2007 Q3 | 379.64 Thousand USD | -5.85% |
| 2007 Q1 | 331.45 Thousand USD | -25.12% |
| 2007 FY | 1.72 Million USD | -31.07% |
| 2007 Q4 | 610.56 Thousand USD | 60.82% |
| 2007 Q2 | 403.25 Thousand USD | 21.66% |
| 2006 Q3 | 311.66 Thousand USD | -65.76% |
| 2006 Q2 | 910.22 Thousand USD | 8.63% |
| 2006 Q1 | 837.93 Thousand USD | -8.98% |
| 2006 FY | 2.5 Million USD | -24.62% |
| 2006 Q4 | 442.63 Thousand USD | 42.02% |
| 2005 Q3 | 720.73 Thousand USD | -16.17% |
| 2005 FY | 3.31 Million USD | 2.7% |
| 2005 Q2 | 859.76 Thousand USD | 10.07% |
| 2005 Q1 | 781.11 Thousand USD | 0.74% |
| 2005 Q4 | 920.59 Thousand USD | 27.73% |
| 2004 Q3 | 720.58 Thousand USD | -8.54% |
| 2004 Q1 | 971.88 Thousand USD | 20.01% |
| 2004 FY | 3.23 Million USD | 4.0% |
| 2004 Q4 | 775.34 Thousand USD | 7.6% |
| 2004 Q2 | 787.88 Thousand USD | -18.93% |
| 2003 Q1 | 805.63 Thousand USD | 60.32% |
| 2003 FY | 3.1 Million USD | 3.58% |
| 2003 Q4 | 809.85 Thousand USD | 10.88% |
| 2003 Q3 | 730.4 Thousand USD | -4.4% |
| 2003 Q2 | 764.04 Thousand USD | -5.16% |
| 2002 Q3 | 781.57 Thousand USD | -13.06% |
| 2002 Q2 | 899 Thousand USD | 3.35% |
| 2002 Q1 | 869.85 Thousand USD | 195.6% |
| 2002 FY | 3 Million USD | -14.09% |
| 2002 Q4 | 502.51 Thousand USD | -35.7% |
| 2001 FY | 3.49 Million USD | -48.79% |
| 2001 Q1 | 1.71 Million USD | -8.48% |
| 2001 Q2 | 1.71 Million USD | -0.49% |
| 2001 Q3 | 1.08 Million USD | -36.67% |
| 2001 Q4 | -909.91 Thousand USD | -183.99% |
| 2000 Q4 | 1.87 Million USD | 16.57% |
| 2000 Q2 | 1.5 Million USD | 25.0% |
| 2000 Q1 | 1.2 Million USD | 9.09% |
| 2000 Q3 | 1.61 Million USD | 7.42% |
| 2000 FY | 6.82 Million USD | 74.91% |
| 1999 FY | 3.9 Million USD | 0.0% |
| 1999 Q1 | 1 Million USD | 0.0% |
| 1999 Q2 | 900 Thousand USD | -10.0% |
| 1999 Q3 | 900 Thousand USD | 0.0% |
| 1999 Q4 | 1.1 Million USD | 22.22% |
| 1998 Q1 | 1 Million USD | 42.86% |
| 1998 Q2 | 1.1 Million USD | 10.0% |
| 1998 Q4 | 1 Million USD | 25.0% |
| 1998 Q3 | 800 Thousand USD | -27.27% |
| 1998 FY | 3.9 Million USD | 14.71% |
| 1997 Q4 | 700 Thousand USD | -12.5% |
| 1997 FY | 3.4 Million USD | -8.11% |
| 1997 Q1 | 900 Thousand USD | 0.0% |
| 1997 Q2 | 1 Million USD | 11.11% |
| 1997 Q3 | 800 Thousand USD | -20.0% |
| 1996 FY | 3.7 Million USD | -7.5% |
| 1996 Q4 | 900 Thousand USD | 12.5% |
| 1996 Q1 | 1 Million USD | 11.11% |
| 1996 Q3 | 800 Thousand USD | -20.0% |
| 1996 Q2 | 1 Million USD | 0.0% |
| 1995 Q2 | 1.2 Million USD | 20.0% |
| 1995 FY | 4 Million USD | 5.26% |
| 1995 Q4 | 900 Thousand USD | -10.0% |
| 1995 Q3 | 1 Million USD | -16.67% |
| 1995 Q1 | 1 Million USD | 11.11% |
| 1994 Q4 | 900 Thousand USD | 0.0% |
| 1994 Q2 | 1 Million USD | 11.11% |
| 1994 Q3 | 900 Thousand USD | -10.0% |
| 1994 Q1 | 900 Thousand USD | 12.5% |
| 1994 FY | 3.8 Million USD | 8.57% |
| 1993 Q1 | 900 Thousand USD | -35.71% |
| 1993 FY | 3.5 Million USD | -20.45% |
| 1993 Q4 | 800 Thousand USD | -11.11% |
| 1993 Q3 | 900 Thousand USD | 0.0% |
| 1993 Q2 | 900 Thousand USD | 0.0% |
| 1992 Q3 | 1.1 Million USD | 10.0% |
| 1992 Q4 | 1.4 Million USD | 27.27% |
| 1992 Q1 | 1 Million USD | -44.44% |
| 1992 Q2 | 1 Million USD | 0.0% |
| 1992 FY | 4.4 Million USD | -21.43% |
| 1991 FY | 5.6 Million USD | 33.33% |
| 1991 Q1 | 1.3 Million USD | -63.89% |
| 1991 Q2 | 1.3 Million USD | 0.0% |
| 1991 Q3 | 1.1 Million USD | -15.38% |
| 1991 Q4 | 1.8 Million USD | 63.64% |
| 1990 Q1 | 200 Thousand USD | 0.0% |
| 1990 Q3 | 200 Thousand USD | 0.0% |
| 1990 Q2 | - USD | -100.0% |
| 1990 Q4 | 3.6 Million USD | 1700.0% |
| 1990 FY | 4.2 Million USD | 223.08% |
| 1989 Q3 | 400 Thousand USD | 0.0% |
| 1989 Q4 | - USD | -100.0% |
| 1989 FY | 1.3 Million USD | -35.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 37.83% |
| Cerus Corporation | 143.15 Million USD | 95.126% |
| OrthoPediatrics Corp. | 137.01 Million USD | 94.907% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 38.579% |
| Talis Biomedical Corporation | 67.18 Million USD | 89.614% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 72.028% |
| Inogen, Inc. | 236.08 Million USD | 97.044% |
| Spectral AI, Inc. | 20.86 Million USD | 66.555% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 87.539% |
| CVRx, Inc. | 76.14 Million USD | 90.836% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -97.789% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 44.127% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.954% |
| Venus Concept Inc. | 80.47 Million USD | 91.329% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 87.667% |
| Bioventus Inc. | 409.91 Million USD | 98.298% |
| BrainsWay Ltd. | 28.01 Million USD | 75.095% |
| Envoy Medical, Inc. | 17.89 Million USD | 61.012% |
| electroCore, Inc. | 32.03 Million USD | 78.215% |
| IceCure Medical Ltd | 16.87 Million USD | 58.651% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 83.555% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 60.427% |
| MaxCyte, Inc. | 84.84 Million USD | 91.776% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 43.779% |
| Nexalin Technology, Inc. | 5.78 Million USD | -20.698% |
| PAVmed Inc | 64.82 Million USD | 89.236% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 86.339% |
| RxSight, Inc. | 103.85 Million USD | 93.281% |
| Sight Sciences, Inc. | 126.44 Million USD | 94.482% |
| SI-BONE, Inc. | 156.35 Million USD | 95.537% |
| TELA Bio, Inc. | 84.18 Million USD | 91.711% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 90.039% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 96.569% |
| LivaNova PLC | 843.54 Million USD | 99.173% |
| 908 Devices Inc. | 68.08 Million USD | 89.75% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.557% |
| Nemaura Medical Inc. | 7.13 Million USD | 2.253% |
| NeuroPace, Inc. | 75.29 Million USD | 90.733% |
| LENSAR, Inc. | 33.33 Million USD | 79.068% |
| Apyx Medical Corporation | 51.01 Million USD | 86.322% |
| Cutera, Inc. | 197.72 Million USD | 96.471% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 71.841% |
| BioSig Technologies, Inc. | 28.53 Million USD | 75.542% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 96.356% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 80.649% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 99.166% |
| Axonics, Inc. | 270.2 Million USD | 97.417% |
| Outset Medical, Inc. | 198.77 Million USD | 96.489% |
| IRIDEX Corporation | 31.81 Million USD | 78.066% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 96.128% |
| IRadimed Corporation | 30.12 Million USD | 76.835% |
| Tivic Health Systems, Inc. | 8.53 Million USD | 18.214% |
| INVO Bioscience, Inc. | 7.85 Million USD | 11.146% |
| Telesis Bio, Inc. | 63.48 Million USD | 89.009% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 92.912% |
| Varex Imaging Corporation | 224.8 Million USD | 96.896% |
| Quipt Home Medical Corp. | 148.66 Million USD | 95.306% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 40.476% |
| Pulmonx Corporation | 112.68 Million USD | 93.808% |
| Dynatronics Corporation | 9.9 Million USD | 29.572% |
| Modular Medical, Inc. | 17.52 Million USD | 60.192% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 65.433% |
| Semler Scientific, Inc. | 38.94 Million USD | 82.082% |
| InMode Ltd. | 215.68 Million USD | 96.765% |
| Bruker Corporation | 1.07 Billion USD | 99.352% |
| Cytosorbents Corporation | 48.33 Million USD | 85.564% |
| DexCom, Inc. | 1.69 Billion USD | 99.587% |
| Align Technology, Inc. | 2.07 Billion USD | 99.664% |
| Viveve Medical, Inc. | 22.17 Million USD | 68.529% |
| ZimVie Inc. | 275.12 Million USD | 97.464% |
| Movano Inc. | 29.69 Million USD | 76.497% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 94.917% |
| Nexalin Technology, Inc. | 5.78 Million USD | -20.698% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -97.789% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.839% |
| Profound Medical Corp. | 33.6 Million USD | 79.234% |
| Insulet Corporation | 939.9 Million USD | 99.258% |
| enVVeno Medical Corporation | 25.23 Million USD | 72.351% |
| Surmodics, Inc. | 98.69 Million USD | 92.93% |
| iCAD, Inc. | 22.22 Million USD | 68.603% |
| Nuwellis, Inc. | 22.61 Million USD | 69.142% |
| Biotricity, Inc. | 17.18 Million USD | 59.394% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 98.435% |
| Aethlon Medical, Inc. | 12.27 Million USD | 43.164% |
| InspireMD, Inc. | 22.95 Million USD | 69.595% |
| PAVmed Inc. | 64.82 Million USD | 89.236% |
| BIOLASE, Inc. | 34.66 Million USD | 79.868% |
| Beyond Air, Inc. | 61.7 Million USD | 88.69% |
| FONAR Corporation | 28.6 Million USD | 75.605% |
| AxoGen, Inc. | 149.33 Million USD | 95.327% |
| Vivani Medical, Inc. | 26.96 Million USD | 74.122% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 96.06% |
| Inari Medical, Inc. | 448.59 Million USD | 98.444% |
| UFP Technologies, Inc. | 58.08 Million USD | 87.987% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -41.611% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -10.441% |
| Tenon Medical, Inc. | 16.96 Million USD | 58.876% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | 5.613% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 84.178% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.353% |
| Sintx Technologies, Inc. | 15.2 Million USD | 54.095% |
| NanoVibronix, Inc. | 4.97 Million USD | -40.318% |
| Quanterix Corporation | 118.1 Million USD | 94.091% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 40.476% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 51.683% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 98.223% |
| TransMedics Group, Inc. | 182.82 Million USD | 96.183% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 75.136% |
| NeuroMetrix, Inc. | 11.09 Million USD | 37.129% |
| Hyperfine, Inc. | 52.87 Million USD | 86.802% |
| Establishment Labs Holdings Inc. | 172 Million USD | 95.943% |
| Bone Biologics Corporation | 9.42 Million USD | 25.989% |
| AVITA Medical, Inc. | 80.77 Million USD | 91.362% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 32.326% |
| Silk Road Medical, Inc | 186.35 Million USD | 96.256% |